Cingulate (CINGW) Assets Average (2022 - 2026)
Cingulate's (CINGW) quarterly Assets Average came in at $24.1 million in Q2 2026, up 88.1% quarter-over-quarter from $12.8 million in Q4 2025.
Analysis
Cingulate (CINGW) Assets Average (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Assets Average for 5 consecutive years, with $24.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average changed N/A year-over-year to $24.1 million; the trailing twelve-month figure through Jun 2026 stood at $24.1 million (changed N/A YoY), and the FY2025 full-year result was $15.0 million, up 63.1% from the prior year.
- Assets Average rose to $24.1 million in Q2 2026 per CINGW's latest filing, from $12.8 million in the prior quarter.
- Across five years, Assets Average topped out at $24.1 million in Q2 2026 and bottomed at $4.5 million in Q1 2024.
- Historically, Assets Average has averaged $11.6 million across 5 years, with a median of $12.8 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Assets Average plunged 65.04% in 2023, then surged 204.19% in 2025.
- Over 5 years, Assets Average stood at $13.4 million in 2022, then slumped by 65.04% to $4.7 million in 2023, then jumped by 203.84% to $14.2 million in 2024, then dropped by 10.03% to $12.8 million in 2025, then soared by 88.1% to $24.1 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $24.1 million, $12.8 million, and $13.7 million for Q2 2026, Q4 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 3.29 Bn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 24.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.07 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Mar 31, 2025 | 13.67 Mn |
| Dec 31, 2024 | 14.22 Mn |
| Sep 30, 2024 | 9.35 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 4.68 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 9.28 Mn |
| Dec 31, 2022 | 13.39 Mn |
| Sep 30, 2022 | 14.59 Mn |
| Jun 30, 2022 | 16.12 Mn |
| Mar 31, 2022 | 20.66 Mn |